| Prevention of bleeding in patients with atrial fibrillation undergoing PCI CM Gibson, R Mehran, C Bode, J Halperin, FW Verheugt, P Wildgoose, ... New England Journal of Medicine 375 (25), 2423-2434, 2016 | 1642 | 2016 |
| Extended thromboprophylaxis with betrixaban in acutely ill medical patients AT Cohen, RA Harrington, SZ Goldhaber, RD Hull, BL Wiens, A Gold, ... New England Journal of Medicine 375 (6), 534-544, 2016 | 503 | 2016 |
| Safety and tolerability of CSL112, a reconstituted, infusible, plasma-derived apolipoprotein AI, after acute myocardial infarction: the AEGIS-I trial (ApoA-I event reducing in … C Michael Gibson, S Korjian, P Tricoci, Y Daaboul, M Yee, P Jain, ... Circulation 134 (24), 1918-1930, 2016 | 188 | 2016 |
| Modified IMPROVE VTE risk score and elevated D-dimer identify a high venous thromboembolism risk in acutely ill medical population for extended thromboprophylaxis AC Spyropoulos, C Lipardi, J Xu, C Peluso, TE Spiro, Y De Sanctis, ... TH open 4 (01), e59-e65, 2020 | 167 | 2020 |
| EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary … CM Gibson, RP Giugliano, RA Kloner, C Bode, M Tendera, A Jánosi, ... European heart journal 37 (16), 1296-1303, 2016 | 155 | 2016 |
| d-Dimer elevation and adverse outcomes R Halaby, CJ Popma, A Cohen, G Chi, MR Zacarkim, G Romero, ... Journal of thrombosis and thrombolysis 39, 55-59, 2015 | 148 | 2015 |
| The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification CM Gibson, AC Spyropoulos, AT Cohen, RD Hull, SZ Goldhaber, ... TH Open 1 (01), e56-e65, 2017 | 130 | 2017 |
| Venous thromboembolism among hospitalized patients with COVID-19 undergoing thromboprophylaxis: a systematic review and meta-analysis G Chi, JJ Lee, A Jamil, V Gunnam, H Najafi, S Memar Montazerin, ... Journal of clinical medicine 9 (8), 2489, 2020 | 117 | 2020 |
| Recurrent Hospitalization Among Patients with Atrial Fibrillation Undergoing Intracoronary Stenting Treated with 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral … CM Gibson, DS Pinto, G Chi, D Arbetter, M Yee, R Mehran, C Bode, ... Circulation 135 (4), 323-333, 2016 | 117 | 2016 |
| Risk factors, imaging findings, and sex differences in spontaneous coronary artery dissection S Sharma, MI Kaadan, JM Duran, F Ponzini, S Mishra, SV Tsiaras, ... The American journal of cardiology 123 (11), 1783-1787, 2019 | 78 | 2019 |
| Association between red blood cell distribution width and mortality and severity among patients with COVID‐19: a systematic review and meta‐analysis JJ Lee, SM Montazerin, A Jamil, U Jamil, J Marszalek, ML Chuang, G Chi Journal of medical virology 93 (4), 2513-2522, 2021 | 71 | 2021 |
| Extended-duration betrixaban reduces the risk of stroke versus standard-dose enoxaparin among hospitalized medically ill patients: an APEX trial substudy (Acute Medically Ill … CM Gibson, G Chi, R Halaby, S Korjian, Y Daaboul, P Jain, D Arbetter, ... Circulation 135 (7), 648-655, 2017 | 70 | 2017 |
| Inverse relationship of serum albumin to the risk of venous thromboembolism among acutely ill hospitalized patients: analysis from the APEX trial G Chi, CM Gibson, Y Liu, AF Hernandez, RD Hull, AT Cohen, ... American Journal of Hematology 94 (1), 21-28, 2019 | 64 | 2019 |
| Current and emerging direct oral anticoagulants: state-of-the-art G Lippi, R Gosselin, EJ Favaloro Seminars in thrombosis and hemostasis 45 (05), 490-501, 2019 | 58 | 2019 |
| Global burden of cardiovascular diseases and risks, 1990-2022 GA Mensah, V Fuster, CJL Murray, GA Roth, ... Journal of the American College of Cardiology 82 (25), 2350-2473, 2023 | 54 | 2023 |
| Asymptomatic deep vein thrombosis is associated with an increased risk of death: insights from the APEX trial A Kalayci, CM Gibson, G Chi, MK Yee, S Korjian, S Datta, T Nafee, ... Thrombosis and Haemostasis 118 (12), 2046-2052, 2018 | 53 | 2018 |
| Comparison of fatal or irreversible events with extended‐duration betrixaban versus standard dose enoxaparin in acutely ill medical patients: an APEX trial substudy CM Gibson, S Korjian, G Chi, Y Daaboul, P Jain, D Arbetter, ... Journal of the American Heart Association 6 (7), e006015, 2017 | 49 | 2017 |
| Association of Anemia with Venous Thromboembolism in Acutely Ill Hospitalized Patients: An APEX Trial Substudy G Chi, CM Gibson, AF Hernandez, RD Hull, SHA Kazmi, A Younes, ... The American Journal of Medicine, 2018 | 45 | 2018 |
| Machine learning to predict venous thrombosis in acutely ill medical patients T Nafee, CM Gibson, R Travis, MK Yee, M Kerneis, G Chi, F AlKhalfan, ... Research and practice in thrombosis and haemostasis 4 (2), 230-237, 2020 | 40 | 2020 |
| The CSL112-2001 trial: safety and tolerability of multiple doses of CSL112 (apolipoprotein AI [human]), an intravenous formulation of plasma-derived apolipoprotein AI, among … CM Gibson, M Kerneis, MK Yee, Y Daaboul, S Korjian, AP Mehr, P Tricoci, ... American heart journal 208, 81-90, 2019 | 37 | 2019 |
